The Cooper Companies, Inc. (COO)

NASDAQ: COO · Real-Time Price · USD

65.91

+0.86 (1.32%)

At close: Jun 18, 2026, 4:00 PM EDT

66.64

+0.73 (1.10%)

After-hours: Jun 18, 2026, 6:26 PM EDT

Revenue

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	Oct '19 Oct 31, 2019	Oct '18 Oct 31, 2018	Oct '17 Oct 31, 2017	Oct '16 Oct 31, 2016	Oct '15 Oct 31, 2015	Oct '14 Oct 31, 2014	Oct '13 Oct 31, 2013
Toric and Multifocal Revenue	1.42B	1.35B	1.26B
Toric and Multifocal Revenue Growth	5.05%	7.49%	10.82%
Sphere, Other Revenue	1.43B	1.39B	1.35B
Sphere, Other Revenue Growth	2.48%	2.98%	4.88%
Total CooperVision Revenue	2.85B	2.74B	2.61B
Total CooperVision Revenue Growth	3.75%	5.15%	7.66%
Office and Surgical Products Revenue	836.00M	824.00M	774.70M
Office and Surgical Products Revenue Growth	1.46%	6.36%	12.36%
Fertility Revenue	548.50M	524.60M	511.30M
Fertility Revenue Growth	4.56%	2.60%	6.52%
Total CooperSurgical Revenue	1.38B	1.35B	1.29B
Total CooperSurgical Revenue Growth	2.66%	4.87%	9.96%
Revenue (Other)	-2.85B	-2.74B	-2.61B
Revenue (Total)	4.23B	4.09B	3.90B
Revenue (Total) Growth	3.39%	5.06%	8.41%

Revenue by Geography

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	Oct '19 Oct 31, 2019	Oct '18 Oct 31, 2018	Oct '17 Oct 31, 2017	Oct '16 Oct 31, 2016	Oct '15 Oct 31, 2015	Oct '14 Oct 31, 2014	Oct '13 Oct 31, 2013
United States Revenue	2.10B	2.05B	1.97B
United States Revenue Growth	2.44%	4.48%	8.48%
Europe Revenue	1.34B	1.25B	1.16B
Europe Revenue Growth	7.07%	8.42%	11.02%
Rest Of The World Revenue	785.10M	785.20M	773.60M
Rest Of The World Revenue Growth	-0.01%	1.50%	4.57%
Revenue (Total)	4.23B	4.09B	3.90B
Revenue (Total) Growth	3.39%	5.06%	8.41%

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	Oct '19 Oct 31, 2019	Oct '18 Oct 31, 2018	Oct '17 Oct 31, 2017	Oct '16 Oct 31, 2016	Oct '15 Oct 31, 2015	Oct '14 Oct 31, 2014	Oct '13 Oct 31, 2013
CooperVision Operating Income	785.10M	729.60M	676.20M
CooperVision Operating Income Growth	7.61%	7.90%	15.06%
CooperSurgical Operating Income	-198.70M	43.40M	118.30M
CooperSurgical Operating Income Growth	-	-63.31%	634.78%
Corporate Operating Income	-88.50M	-90.10M	-88.80M
Operating Income (Total)	497.90M	682.90M	705.70M
Operating Income (Total) Growth	-27.09%	-3.23%	32.38%

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	Oct '19 Oct 31, 2019	Oct '18 Oct 31, 2018	Oct '17 Oct 31, 2017	Oct '16 Oct 31, 2016	Oct '15 Oct 31, 2015	Oct '14 Oct 31, 2014	Oct '13 Oct 31, 2013
CooperVision - Constant Currency Revenue Growth	5.00%	8.00%
CooperSurgical - Constant Currency Revenue Growth	5.00%	11.00%
Total Company - Constant Currency Revenue Growth	5.00%	9.00%
CooperVision - Organic Revenue Growth	5.00%	9.00%
CooperSurgical - Organic Revenue Growth	3.00%	5.00%
Total Company - Organic Revenue Growth	4.00%	8.00%